Skip to content

Drug interactions

Lidocaine-prilocaine + Ponatinib

Severity: Minor

Lidocaine-prilocaine and Ponatinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ponatinib inhibits P-glycoprotein and could modestly raise exposure to P-gp substrates. Lidocaine is a minor P-gp substrate and topical absorption is low, so the practical effect is expected to be negligible.

What this interaction means in plain words

Lidocaine-prilocaine and Ponatinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Lidocaine-prilocaine belongs to Genitourinary; Ponatinib belongs to Oncology.

Evidence level: Low

Why it happens

P-glycoprotein inhibition by ponatinib may reduce lidocaine efflux.

What to do

No specific action is needed for standard topical use. Avoid excessive dosing.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lidocaine-prilocaine and Ponatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Lidocaine-prilocaine with Ponatinib?

MediHelp rates the interaction as minor. Lidocaine-prilocaine and Ponatinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Ponatinib inhibits P-glycoprotein and could modestly raise exposure to P-gp substrates. Lidocaine is a minor P-gp substrate and topical absorption is low, so the practical effect is expected to be negligible.

How serious is the interaction between Lidocaine-prilocaine and Ponatinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No specific action is needed for standard topical use. Avoid excessive dosing.

What other medicines interact with Lidocaine-prilocaine?

MediHelp also lists interactions of Lidocaine-prilocaine with, for example, Phenazopyridine, Bupivacaine implant, Bupivacaine liposome. The full list is on the Lidocaine-prilocaine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in